Italian Pulmonary Embolism Registry - IPER

Acute Pulmonary Embolism Clinical Trial

— IPER  

Official title:

Italian Pulmonary Embolism Registry

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01604538
• Other study ID #: protocol_364
• Status: Completed
• Phase: N/A
• First received: May 21, 2012
• Last updated: May 21, 2012
• Start date: March 2006

Study information

• Verified date: May 2012
• Source: University Of Perugia
• Contact: n/a
• Is FDA regulated: No
• Health authority: Italy: Osservatorio Nazionale Sperimentazioni Cliniche
• Study type: Observational

Clinical Trial Summary

RAZIONALE

Pulmonary embolism is a complex disease, with a highly variable clincal presentation. Diagnosis starts with clinical probability assessment mainly based on medical history and rapidly available clinical data. Pulmonary embolism can be managed by emergency department, cardiology, pneumology geriatrics or internal medicine physicians. Thus, initial clinical management can varies based on the attitude of the attending physician.

Diagnosis is a crucial point as it can influence short term mortality.

OBJECTIVE

The registry has 3 main objectives:

1. educational objective,

2. improvement in the knowledge of epidemiology, management and outcome of acute pulmonary embolism in Italy

3. scientific objective

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1700
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• consecutive patients with acute pulmonary embolism

Exclusion Criteria:

• age <18 years

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Acute Pulmonary Embolism
• Embolism
• Pulmonary Embolism

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University Of Perugia